Search

everythinglearnresearchcommunity

for

Search:↓

The consensus document recommends a comprehensive treatment plan for Hidradenitis Suppurativa, including various medications, surgery, lifestyle changes, and the need for more research and resources.

New treatments for a chronic skin condition show promise, but individualized plans are crucial due to varying responses.

Some drugs used to treat inflammation may cause hair loss.

Biologics show promise in treating various stubborn skin diseases, but more research and better reimbursement criteria are needed.

The study found key factors in the cause of hidradenitis suppurativa, its link to other diseases, and identified existing drugs that could potentially treat it.

Brodalumab effectively treated a man's severe hand and foot psoriasis.

Infliximab improved skin and bowel symptoms in Crohn's disease but caused side effects and the disease returned after stopping treatment.

TNF-inhibitor induced alopecia can be treated effectively with different therapies.

Increased HIF-1α is linked to the inflammation and severity of hidradenitis suppurativa, suggesting treatments that lower HIF-1α could help.

Tofacitinib improved ulcerative colitis, skin ulcers, and hair loss in a patient who didn't respond well to other treatments.

The document concludes that proper treatment and management of plaque psoriasis in adolescents can improve their quality of life.

Ixekizumab helps improve life quality, physical ability, and work performance in patients with psoriatic arthritis who haven't used biologic drugs before.

Personalized medicine in dermatology uses molecular biomarkers to improve diagnosis and treatment but needs further advancements for practical use.

Early treatment is key for permanent hair loss disorders, with options ranging from medications and phototherapy to immunomodulators and antibiotics, depending on severity and type.

Skin changes during pregnancy are common, and non-invasive imaging is safe for monitoring these changes.

A girl with Crohn's disease developed hair loss due to her increased medication, a rare side effect seen in some children.

Hidradenitis Suppurativa has genetic links, with certain gene mutations more common in patients and a third of cases having a family history.

Certain surgical methods are better than routine incision for hidradenitis suppurativa, topical clindamycin and acitretin are effective treatments, men with HS have a risk of skin cancer, HS patients are more likely to die from heart problems, and specific genetic markers are linked to treatment response.

Hidradenitis Suppurativa is likely an autoinflammatory disease, and better understanding its causes could improve treatments.

In 2017, pediatric dermatology advanced with new treatments and insights into various skin conditions in children.

Treatment with biologic agents can significantly improve psoriasis symptoms, and blood biomarkers could potentially predict individual patient's response to treatment.

The issue concluded that various skin conditions have different effective treatments and factors influencing them.

Real-life dosing of biologics for plaque psoriasis often deviates from recommended guidelines, especially for high-need patients.

Biologic agents can be effective for rheumatic diseases but have risks like infections and require careful monitoring and patient information.

A multi-tiered treatment approach is crucial for managing hidradenitis suppurativa in patients with intellectual and developmental disabilities.

A multi-tiered treatment approach is crucial for managing hidradenitis suppurativa in patients with intellectual and developmental disorders.

AGA might indicate higher risk for severe COVID-19.

HS patients rarely see dermatologists, often get opiates, and need better care.

Some drugs may increase the risk of obstructive sleep apnea, while others like certain biologics might decrease it.

Understanding drug interactions, side effects, and patient-specific factors is crucial for effective dermatological care.